新興生物科技 EBS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 12.36 | 523 | -9.88 | -55 | -3.93 | 1,319 |
| 2025Q3 | 8.82 | 583 | 9.15 | 51 | 3.56 | 1,461 |
| 2025Q2 | 6.38 | 536 | -2.20 | -12 | -0.84 | 1,417 |
| 2025Q1 | 4.86 | 553 | 13.13 | 68 | 4.83 | 1,426 |
| 2024Q4 | 9.56 | 483 | -6.32 | -31 | -2.18 | 1,390 |
| 2024Q3 | 8.35 | 508 | 25.66 | 115 | 7.68 | 1,478 |
| 2024Q2 | 6.82 | 386 | -53.91 | -283 | -17.07 | 1,514 |
| 2024Q1 | 2.53 | 664 | 1.37 | 9 | 0.50 | 1,804 |
| 2023Q4 | 2.40 | 649 | -7.35 | -50 | -2.66 | 1,823 |
| 2023Q3 | 3.40 | 697 | -31.86 | -263 | -12.94 | 1,893 |
| 2023Q2 | 7.35 | 956 | -23.91 | -258 | -10.07 | 2,179 |
| 2023Q1 | 10.36 | 1,203 | -14.13 | -183 | -5.98 | 2,950 |
| 2022Q4 | 11.81 | 1,388 | -4.72 | -67 | -2.21 | 3,166 |
| 2022Q3 | 20.99 | 1,449 | -5.11 | -76 | -2.68 | 2,909 |
| 2022Q2 | 31.04 | 1,513 | -3.65 | -56 | -2.05 | 2,735 |
| 2022Q1 | 41.06 | 1,575 | -0.23 | -4 | -0.13 | 2,780 |
| 2021Q4 | 43.47 | 1,619 | 12.05 | 189 | 6.50 | 2,959 |
| 2021Q3 | 50.07 | 1,523 | -2.13 | -33 | -1.13 | 2,868 |
| 2021Q2 | 62.99 | 1,544 | 0.30 | 5 | 0.16 | 2,915 |
| 2021Q1 | 92.91 | 1,523 | 4.69 | 70 | 2.41 | 2,900 |